News

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.
After reviewing all the data and considering input from regulators, Pfizer decided to discontinue the danuglipron program.
Emactuzumab, a humanized immunoglobulin G1 monoclonal antibody, targets the CSF-1 receptor and inhibits macrophages in tumor tissue.
Both the FDA and Novo Nordisk are advising patients and providers to check their supplies of Ozempic for counterfeit product. Individuals in possession of a counterfeit product are urged to call Novo ...
Substantially elevated GAS incidence rates seen in people experiencing homelessness, people who inject drugs, long-term care facility residents ...
The Food and Drug Administration (FDA) has approved a tablet formulation of Livmarli ® (maralixibat).
The CDC has long urged vaccination for international travelers, but the recommendation for domestic travelers is a response to the ongoing outbreaks across the US.
Major health groups, including Autism Speaks, agree that childhood vaccines do not cause autism. Autism is a developmental condition that can cause problems with language, learning and social skills.
Icotrokinra appears to be an effective treatment for adolescent patients with moderate to severe plaque psoriasis, according to a subgroup analysis of the ICONIC-LEAD study.
Patients carrying 2 copies of the APOE4 gene (APOE4/4 homozygotes) are more likely to develop AD earlier in life than those without APOE4.
The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.
Based on these findings, the USPSTF concludes that primary care behavioral counseling interventions to support breastfeeding have a moderate net benefit, with moderate certainty. Interventions or ...